199 related articles for article (PubMed ID: 29395638)
1. Lenalidomide-Induced Ischemic Cerebrovascular Disease in Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes Syndrome.
Mitsutake A; Matsumoto H; Hatano K; Irie K; Tsukada N; Hashida H
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):e102-e103. PubMed ID: 29395638
[TBL] [Abstract][Full Text] [Related]
2. Polyneuropathy, organomegaly, endocrinopathy, monoclonal band, and skin (POEMS) changes syndrome presenting with a pseudosensory level: a case report.
Paranavitane S; Gooneratne L; Chang T
J Med Case Rep; 2019 Dec; 13(1):384. PubMed ID: 31878962
[TBL] [Abstract][Full Text] [Related]
3. Lenalidomide and dexamethasone in patients with POEMS syndrome: results of a prospective, open-label trial.
Nozza A; Terenghi F; Gallia F; Adami F; Briani C; Merlini G; Giordano L; Santoro A; Nobile-Orazio E
Br J Haematol; 2017 Dec; 179(5):748-755. PubMed ID: 29048107
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide as frontline therapy in polyneuropathy, organomegaly, endocrinopathy, monoclonal protein and skin changes syndrome: a retrospective case series of eight patients.
Lestang E; Caristan A; Néel A; Graveleau J; Duhamel E; Masseau A; Connault J; Maisonneuve H; Le Gouill S; Blin N; Touzeau C; Moreau P; Hamidou M
Leuk Lymphoma; 2015 Jun; 56(6):1895-6. PubMed ID: 25347429
[No Abstract] [Full Text] [Related]
5. POEMS syndrome: complex factors contributing to a delayed diagnosis.
Robey RC; Campus C; Ringuette B; Shumate M
BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26621905
[TBL] [Abstract][Full Text] [Related]
6. Surgical revascularization for quasi-moyamoya disease associated with polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome: a case report and literature review.
Kubota Y; Hanaoka Y; Koyama JI; Takahashi Y; Katoh N; Iwaya M; Fujii Y; Ogiwara T; Horiuchi T
Nagoya J Med Sci; 2023 Feb; 85(1):141-149. PubMed ID: 36923610
[TBL] [Abstract][Full Text] [Related]
7. Lenalidomide Treatment for Thalidomide-refractory POEMS Syndrome: A Prospective Single-arm Clinical Trial.
Suichi T; Misawa S; Nagashima K; Sato Y; Iwai Y; Katayama K; Sekiguchi Y; Shibuya K; Amino H; Suzuki YI; Tsuneyama A; Nakamura K; Kuwabara S
Intern Med; 2020 May; 59(9):1149-1153. PubMed ID: 32009091
[TBL] [Abstract][Full Text] [Related]
8. Pachymeningeal involvement in POEMS syndrome: dramatic cerebral MRI improvement after lenalidomide therapy.
Briani C; Manara R; Lessi F; Citton V; Zambello R; Adami F
Am J Hematol; 2012 May; 87(5):539-41. PubMed ID: 22389216
[TBL] [Abstract][Full Text] [Related]
9. A prospective phase II study of low dose lenalidomide plus dexamethasone in patients with newly diagnosed polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (POEMS) syndrome.
Li J; Huang XF; Cai QQ; Wang C; Cai H; Zhao H; Zhang L; Cao XX; Gale RP; Zhou DB
Am J Hematol; 2018 Jun; 93(6):803-809. PubMed ID: 29603764
[TBL] [Abstract][Full Text] [Related]
10. Improvement of sexual function in POEMS syndrome after combination therapy of Lenalidomide and dexamethasone.
Yang H; Huang X; Cai Q; Wang C; Cao X; Zhou D; Li J
Orphanet J Rare Dis; 2016 Jun; 11(1):80. PubMed ID: 27317315
[TBL] [Abstract][Full Text] [Related]
11. Daratumumab plus lenalidomide and dexamethasone for relapsed POEMS syndrome with bone plasmacytoma harboring 17p deletion.
Oyama T; Taoka K; Chiba A; Masamoto Y; Ikemura M; Honda A; Maki H; Kurokawa M
Int J Hematol; 2023 Mar; 117(3):463-467. PubMed ID: 36202948
[TBL] [Abstract][Full Text] [Related]
12. Acute carotid obliteration: a new vascular manifestation in POEMS syndrome.
Erro ME; Lacruz F; Aymerich N; Ayuso T; Soriano G; Gállego J; Villanueva JA
Eur J Neurol; 2003 Jul; 10(4):383-4. PubMed ID: 12823489
[TBL] [Abstract][Full Text] [Related]
13. An Adult with Polyneuropathy and Hypogonadism due to Poems Syndrome.
Zaidi S; Sattar S; Asumal KB
J Coll Physicians Surg Pak; 2017 Oct; 27(10):651-653. PubMed ID: 29056130
[TBL] [Abstract][Full Text] [Related]
14. [Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].
Ohashi K; Yokoyama A; Kagoo T; Hosoda T; Yamamoto R; Yoneda M; Kudo M; Boku S; Ueno H; Yano T
Rinsho Ketsueki; 2013 Jul; 54(7):670-4. PubMed ID: 23912352
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patients.
Royer B; Merlusca L; Abraham J; Musset L; Haroche J; Choquet S; Leleu X; Sebban C; Decaux O; Galicier L; Roussel M; Recher C; Banos A; Guichard I; Brisseau JM; Godmer P; Hermine O; Deplanque G; Facon T; Asli B; Leblond V; Fermand JP; Marolleau JP; Jaccard A
Am J Hematol; 2013 Mar; 88(3):207-12. PubMed ID: 23335406
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia.
Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H
J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674
[TBL] [Abstract][Full Text] [Related]
17. Skin Responses in Newly Diagnosed Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome After Therapy With Low-Dose Lenalidomide Plus Dexamethasone.
Gao Y; Zhang S; Yang L; Li J; Liu Y; Wang T
Front Immunol; 2021; 12():681360. PubMed ID: 34025681
[TBL] [Abstract][Full Text] [Related]
18. POEMS syndrome: diagnostic delay and successful treatment with lenalidomide, cyclophosphamide and prednisone followed by autologous peripheral stem cell transplantation.
Ordway S; Gilbert L; Wanko S
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30054320
[TBL] [Abstract][Full Text] [Related]
19. Moyamoya Disease-like Cerebrovascular Stenotic Lesions Are an Important Phenotype of POEMS Syndrome-associated Vasculopathy.
Takahashi Y; Mochizuki Y; Nakamura K; Katoh N; Sekijima Y
Intern Med; 2022 May; 61(10):1603-1608. PubMed ID: 34744103
[TBL] [Abstract][Full Text] [Related]
20. POEMS Syndrome: Therapeutic Options.
Jaccard A
Hematol Oncol Clin North Am; 2018 Feb; 32(1):141-151. PubMed ID: 29157615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]